Nexus Surgical and Medicare's Stock Surges, Outperforms Market with Impressive Growth

Jul 18 2024 10:10 AM IST
share
Share Via
Nexus Surgical and Medicare, a microcap company in the finance/NBFC industry, has seen a surge in its stock price, reaching a 52-week high of Rs.21 on July 18, 2024. The stock has outperformed the sector by 3.3% and has been on a positive trend, trading higher than its moving averages. In the past year, the stock has risen by 117.03%, showcasing the company's strong performance and potential for growth. However, this article does not provide any recommendations or predictions about the company's future potential. Investors are advised to conduct their own research before making any decisions.

Nexus Surgical and Medicare, a microcap company in the finance/NBFC industry, has recently seen a surge in its stock price. On July 18, 2024, the company's stock reached a 52-week high of Rs.21. This has caught the attention of investors and market analysts, with MarketsMOJO giving a 'Sell' call for the stock.

The stock has been performing well, outperforming the sector by 3.3% and gaining for the last 8 consecutive days. In this period, the stock has risen by 34.84%. Additionally, Nexus Surgical is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend.

In comparison to the overall market performance, Nexus Surgical has shown impressive growth. In the past year, the company's stock has risen by 117.03%, while the Sensex has only seen a 20.95% increase. This showcases the company's strong performance and potential for growth.

Nexus Surgical and Medicare is a microcap company, which means it has a market capitalization of less than $300 million. Despite its small size, the company has managed to attract attention with its recent stock performance. However, it is important to note that this article is not making any recommendations or predictions about the company's future potential. Instead, it is presenting factual information about the company's recent stock performance. Investors are advised to do their own research and make informed decisions.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News